ASHLEY MORRISON: Open Payments
NPI 1396459301 · SAN DIEGO, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$817 in 16 payments from 9 companies in 2025. Trend: 2023 $544 · 2024 $791 · 2025 $817
Food & beverage: $817
| Company | Payments | Amount |
|---|---|---|
| Gilead Sciences, Inc. | 5 | $214 |
| Neurocrine BioSciences, Inc. | 1 | $154 |
| Novo Nordisk Inc | 2 | $148 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $125 |
| Lilly USA, LLC | 2 | $55 |
| AstraZeneca Pharmaceuticals LP | 2 | $42 |
| Janssen Pharmaceuticals, Inc | 1 | $31 |
| Hologic Sales and Service, LLC | 1 | $25 |
| SANOFI PASTEUR INC. | 1 | $24 |
Products named: INGREZZA, XIFAXAN, Wegovy, Yeztugo, MOUNJARO, SPRAVATO, BREZTRI, APTIMA.
Industry payments across CA — which companies pay providers there.
